Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With EGFR-Positive Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating efficacy and safety of MRG003 in EGFR-positive advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• MRG003

Snippet

Sponsor: Shanghai Miracogen Inc. | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: UNKNOWN